Yesterday, July 12, 2022, at the ISTH annual meeting in London, England, the research staff of Precision BioLogic Inc., Dartmouth, Nova Scotia, Canada presented the poster:
Quinton T, Fraser J, Black KM, Sadeghi-Khomami A. Performance of a chromogenic factor IX activity assay in the recovery of factor IX replacement therapies, Abstract PB1183. Their data illustrate that PBI’s Chromogenic Factor IX assay accurately measures FIX activity in plasma samples with AlphaNine, Alprolix, BeneFIX, Ixinity, Rebinyn, and Rixubis.
No comments here.